INBX
Inhibrx·NASDAQ
--
--(--)
--
--(--)
INBX fundamentals
Inhibrx (INBX) released its earnings on Aug 13, 2025: revenue was 1.30M (YoY +1200.00%), beat estimates; EPS was -1.85 (YoY -101.47%), beat estimates.
Revenue / YoY
1.30M
+1200.00%
EPS / YoY
-1.85
-101.47%
Report date
Aug 13, 2025
Earnings Call
4:00 PM on Aug 13, 2025
Meeting link.EPS
Actual | -3.09 | -1.85 |
Forecast | -2.885 | -2.76 |
Surprise | -7.11% | +32.97% |
Revenue
Actual | 100.00K | 1.30M |
Forecast | 0 | 0 |
Surprise | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What guidance did Inhibrx's management provide for the next earnings period?What factors drove the changes in Inhibrx's revenue and profit?What were the key takeaways from Inhibrx’s earnings call?What is Inhibrx's latest dividend and current dividend yield?Did Inhibrx beat or miss consensus estimates last quarter?What is Inhibrx's gross profit margin?What is the revenue and EPS growth rate for Inhibrx year over year?What does Inhibrx do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
